CBP/KAT3A Antibody (2H5) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # H00001387-M01
Key Product Details
Species Reactivity
Human
Applications
Western Blot, ELISA, Sandwich ELISA, Immunocytochemistry/ Immunofluorescence, Proximity Ligation Assay
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 kappa Clone # 2H5
Format
Azide and BSA Free
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CREBBP (NP_004371, 951 a.a. ~ 1050 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. PVHAQPPGTPLSQAAASIDNRVPTPSSVASAETNSQQPGPDVPVLEMKTETQAEDTEPDPGESKGEPRSEMMEEDLQGASQVKEETDIAEQKSEPMEVDE
Specificity
CREBBP - CREB binding protein (Rubinstein-Taybi syndrome)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Description
Quality control test: Antibody Reactive Against Recombinant Protein.
Scientific Data Images for CBP/KAT3A Antibody (2H5) - Azide and BSA Free
![Immunocytochemistry/ Immunofluorescence: CBP/KAT3A Antibody (2H5) [H00001387-M01]](https://resources.bio-techne.com/images/products/CBP-KAT3A-Antibody-2H5-Immunocytochemistry-Immunofluorescence-H00001387-M01-img0005.jpg "Immunocytochemistry/ Immunofluorescence: CBP/KAT3A Antibody (2H5) [H00001387-M01]")
Immunocytochemistry/ Immunofluorescence: CBP/KAT3A Antibody (2H5) [H00001387-M01]
Immunocytochemistry/Immunofluorescence: CBP/KAT3A Antibody (2H5) [H00001387-M01] - Analysis of monoclonal antibody to CREBBP on HeLa cell . Antibody concentration 10 ug/ml.![Proximity Ligation Assay: CBP/KAT3A Antibody (2H5) [H00001387-M01]](https://resources.bio-techne.com/images/products/CBP-KAT3A-Antibody-2H5-Proximity-Ligation-Assay-H00001387-M01-img0003.jpg "Proximity Ligation Assay: CBP/KAT3A Antibody (2H5) [H00001387-M01]")
Proximity Ligation Assay: CBP/KAT3A Antibody (2H5) [H00001387-M01]
Proximity Ligation Assay: CBP/KAT3A Antibody (2H5) [H00001387-M01] - Protein-protein interactions between FGFR1 and CREBBP HeLa cells were stained with anti-FGFR1 (H00002260-D01P) rabbit purified polyclonal 1:1200 and anti-CREBBP mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).
Sandwich ELISA: CBP/KAT3A Antibody (2H5) [H00001387-M01] - Detection limit for recombinant GST tagged CREBBP is approximately 0.03ng/ml as a capture antibody.
Applications for CBP/KAT3A Antibody (2H5) - Azide and BSA Free
Application
Recommended Usage
Western Blot
1:500
Application Notes
Antibody reactivity against recombinant protein with GST tag on ELISA and WB. GST tag alone is used as a negative control. It has been use for IF.
Formulation, Preparation, and Storage
Purification
IgG purified
Formulation
In 1x PBS, pH 7.4
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Background: CBP
The CBP (CREB-binding Protein) is a histone acetyltransferase and transcriptional coactivator that regulates RNA polymerase II transcription. In addition to histone acetylation, CBP also acetylates various transcription factors, including the tumor suppressor protein p53, to enhance sequence-specific DNA binding.
Long Name
CREB-binding Protein
Alternate Names
CREBBP, RTS
Entrez Gene IDs
1387 (Human)
Gene Symbol
CREBBP
UniProt
Additional CBP Products
Product Documents for CBP/KAT3A Antibody (2H5) - Azide and BSA Free
Product Specific Notices for CBP/KAT3A Antibody (2H5) - Azide and BSA Free
This product is produced by and distributed for Abnova, a company based in Taiwan.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...